De La Rosa, Olga,Lombardo, Eleuterio,Dalemans, Wilfried
申请号：
AU2014230014
公开号：
AU2014230014B2
申请日:
2014.03.17
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The present invention provides a method for determining the clinical prognosis of a human subject to the administration of a pharmaceutical composition comprising of stem cells (preferably mesenchymal stem cells), stromal cells,regulatory T-cells, fibroblasts and combinations thereof.
